CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--HemoShear, LLC, a developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds in the laboratory announces the formation of a new division, HepaShear, to develop an advanced human surrogate model of the liver.
